Monitor future Form 4 filings by Lonnel Coats for any open-market purchases or grants of equity, which would signal insider conviction or compensation alignment. No immediate trading signal from this filing alone.
Price Chart
Executive Summary
Lonnel Coats filed an initial Statement of Beneficial Ownership (Form 3) with the SEC, reporting zero beneficial ownership of Mineralys Therapeutics securities as of October 19, 2026. The filing is a routine administrative requirement for a newly appointed officer or director and contains no material financial information.
Key Facts
- Lonnel Coats filed Form 3 on October 20, 2026, reporting beneficial ownership as of October 19, 2026.
- Coats reported zero shares, zero derivative securities, and zero other ownership.
- The filing includes a power of attorney authorizing Jon Congleton, Adam Levy, Jose Breton, and Jeffrey Munsie to file Section 16 reports on his behalf.
- Coats' business address is c/o Mineralys Therapeutics, 150 N. Radnor Chester Road, Suite F200, Radnor, PA 19087.
Financial Impact
No financial impact, the filing reports zero beneficial ownership and is a routine initial statement.
Risk Factors
- No material risks identified from this administrative filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001612528-26-000001 |
| Document: 0001612528-26-000001-index-headers.html | 0001612528-26-000001 |
| Document: 0001612528-26-000001-index.html | 0001612528-26-000001 |
| Document: 0001612528-26-000001.txt | 0001612528-26-000001 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 today | Press Release | $20.59 | awaiting T+20 | awaiting T+20 | $21.38 (+3.84%) |
Oct 20, 2026 8d ago | 3 | $21.10 | awaiting T+20 | awaiting T+20 | $21.38 (+1.33%) |
Oct 20, 2026 8d ago | 3 | $21.10 | awaiting T+20 | awaiting T+20 | $21.38 (+1.33%) |
Oct 19, 2026 9d ago | 8-K | $21.58 | awaiting T+20 | awaiting T+20 | $21.38 (−0.93%) |
Oct 13, 2026 15d ago | 144 | $20.76 | awaiting T+20 | awaiting T+20 | $21.38 (+2.99%) |
Sep 30, 2026 28d ago | 144 | $23.72 | awaiting T+20 | awaiting T+20 | $21.38 (−9.87%) |
Sep 29, 2026 29d ago | Press Release | $25.13 $21.13 | ▼ −15.92% | ▼ −16.84% | $21.38 (−14.92%) |
Sep 24, 2026 4w ago | Insider Cluster | $25.86 $20.55 | ▲ +20.53% | ▲ +19.06% | $21.38 (+17.32%) |
Sep 22, 2026 5w ago | Insider Cluster | $26.89 $21.10 | ▼ −21.53% | ▼ −22.22% | $21.38 (−20.49%) |
Aug 12, 2026 10w ago | 3 | $26.09 $28.20 | ▲ +8.09% | ▲ +9.83% | $21.38 (−18.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers